Sanofi — Director's Dealing 2015

Nov 18, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Voyager Therapeutics, Inc. (VYGR)
CIK: 0001640266
Period of Report: 2015-11-16

Reporting Person: Sanofi (Former 10% owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-11-10	Common stock Par value per share $ 0.001	C	2352941	—	Acquired	2352941	Indirect
2015-11-16	Common stock Par value per share $ 0.001	P	125000	$14	Acquired	2477941	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-11-10	Shares of Series B convertible preferred stock	$0	C	10000000	Disposed		Common stocks (2352941)	Indirect

Footnotes

F1: Conversion upon Initial Public Offering